多重共病老年人对临床试验要素的偏好:全国代表性调查
该研究对1318名≥65岁、≥3种慢性病的美国老年人进行横断面调查,了解其参加药物试验的意愿及对试验要素的偏好。结果显示近半数人愿考虑记忆、高血压、癌症等药物试验,多数偏好医生办公室获取信息、书面材料及问答环节,并倾向每月或每3-4月随访、单程30分钟旅行。
要点
- 近半数多重共病老年人愿考虑记忆、高血压、癌症等药物试验。
- 多数偏好从医生办公室获取试验信息,并希望书面材料与问答环节。
- 偏好每月或每3-4月随访,愿单程旅行30分钟,不倾向低频接触的实用试验。
核心结论
- 增加多重共病老年人及少数种族老年人入组需加强医生参与。
- 低频接触的实用试验不太可能提高多重共病老年人的参与度。
研究设计与样本
- 2023年3-4月对NORC芝加哥大学Foresight 50+小组进行横断面互联网和电话调查。
- 样本为≥65岁、≥3种慢性病的全国代表性样本,共1318人(互联网1142人,电话176人)。
主要发现
- 平均年龄72.3±6.3岁,52%为女性;83%白人,10%黑人或非裔美国人,5%西班牙裔或拉丁裔,1.1%亚裔。
- 被查询的16种慢性病中平均患4.4±1.9种,平均服用7.5±3.3种药物。
- 近半数愿考虑记忆问题、高血压、癌症、慢性疼痛、糖尿病或高胆固醇的药物试验;男性和黑人或非裔美国人受访者最愿考虑高血压或糖尿病试验。
- 偏好从医生办公室了解试验信息者总体87%,黑人或非裔美国人85%,西班牙裔94%;考虑老年中心者白人10%,黑人或非裔美国人30%,西班牙裔20%(p<0.001)。
- 三分之二希望书面材料和问答环节,无显著性别或种族差异;受访者预计在家测血压无困难,仅>80岁者预计佩戴活动监测设备有困难。
临床怎么用
- 招募多重共病老年人参与药物试验时,应通过医生办公室主动介绍并加强医生参与。
- 提供书面材料并安排问答环节,随访频率可设为每月或每3-4月,并考虑单程30分钟旅行可接受。
- 对>80岁老年人需关注佩戴活动监测设备的困难,不依赖低频接触的实用试验设计来提高参与度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Older adults with multimorbidity have been under-represented in clinical drug trials. We sought to determine willingness to enroll in trials and preferences of older adults for learning about clinical trials, visit frequency, travel, locations, and testing. METHODS: Cross-sectional internet and telephone survey of a nationally representative sample of adults ≥ 65 years with ≥ 3 chronic conditions (NORC University of Chicago Foresight 50+ panel) from March-April 2023 to determine acceptability of aspects of clinical trials. RESULTS: Surveyed 1318 (1142 Internet, 176 phone), mean age 72.3 ± 6.3 (SD), 52% women; race: 83% White, 10% Black or African American (BLAfrAm), 5% Hispanic or Latino, 1.1% Asian; 4.4 ± 1.9 chronic conditions (of 16 queried), taking 7.5 ± 3.3 medications. Almost half would consider trials of medications for memory problems, hypertension, cancer, chronic pain, diabetes, or high cholesterol. Men and BLAfrAm respondents were the most willing to consider hypertension or diabetes trials. Preferences for where to learn about trials were physician offices (87% overall, 85% of BLAfrAm, 94% of Hispanic); 10% of White respondents considered senior centers versus 30% of BLAfrAm and 20% of Hispanics (p < 0.001). Two-thirds wanted written materials and question and answer sessions (no significant sex or racial differences). Respondents anticipated no difficulty with measuring blood pressure at home, and only respondents > 80 years anticipated difficulty wearing activity monitoring devices. All groups preferred monthly or every 3-4 month visits for physical exams, blood or urine tests vs. less frequently and were willing to travel half an hour in each direction for visits. CONCLUSIONS: Efforts to increase enrollment of older adults and older adults from previously under-represented racial populations will need increased physician engagement. Pragmatic trials with infrequent participant contact are not likely to increase participation of older adults with multimorbidity.
引用
- Schwartz JB, Liu RY, Boscardin J, et al. Preferences Regarding Clinical Drug Trial Elements: A Nationally Representative Survey of Older Adults With Multimorbidity. J Am Geriatr Soc. 2025. PMID: 40251943. doi:10.1111/jgs.19470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。